Ratings & Reviews performance provides an overview of what users think of your app. Here are the key metrics to help you identify how your app is rated by users and how successful is your review management strategy.
Intravenous Medications contains everything needed for the safe and effective administration of IV drugs. Updated annually, this comprehensive resource contains detailed monographs that include dosage, administration, contraindications, precautions, interactions, antidotes, and more. Avoid errors by using the built-in calculator to determine precise dilution and rate of administration. Download this app to provide better patient care with fast access anytime, anywhere. Features of Intravenous Medications include: • 400+ detailed generic and trade name IV drug monographs • Helpful calculator and charts for dilution and rate of administration • Black Box Warnings highlighting critical information • Age-specific dose variances for geriatric, pediatric, infant, and neonatal patients • The latest FDA-approved drug listings • Both Full Text and Universal Index Search help you find terms fast • “Favorites” for bookmarking important entries FREE 30-DAY TRIAL: WHAT TO EXPECT • First-time users can access Unbound's complete IV Medications Gahart mobile app free for 30 days • After 30 days, your iTunes account will be charged $49.99 for a one-year subscription unless you have turned off auto-renew at least 24 hours before the free trial ends. • To manage your subscriptions, open Apple's “Settings” app and tap on the “iTunes & App Store" entry. Tap your Apple ID at the top of the screen and login. Tap subscriptions, then tap the subscription you wish to manage. •NOTE: If you choose not to purchase a subscription, content will no longer be viewable after the free trial period. iTunes automatic renewal feature: Your subscription automatically renews unless auto-renew is turned off 24 hours prior to the conclusion of your current 12 month period. Your iTunes account will automatically be charged the current renewal rate ($49.99) within 24 hours prior to the end of the subscription period. This will ensure you receive all updates and continued web access for the following year. If you choose not to renew, you will be able to use the app, however will not receive updates. Authors: Betty L. Gahart, RN; Adrienne R. Nazareno, PharmD, Meghan Q. Ortega, RN, BSN Publisher: Elsevier Powered by: Unbound Medicine Unbound Privacy Policy: www.unboundmedicine.com/privacy Unbound Terms of Use: https://www.unboundmedicine.com/end_user_license_agreement
